News Archives - Page 2 of 78

TuesdayApr 02, 2024 3:56 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives New Epilepsy, Anti-Viral Agent Patents

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has received three new patent awards. According to the announcement, the company was awarded two new patents in its epilepsy patent family; both awards were granted in the United States. The U.S. patents, which cover both swallowed capsules and dissolvable oral tablets, complement research indicating DehydraTECH-CBD has potential to decrease epileptic seizures in rodents and to be absorbed into the bloodstream more effectively than the current treatments. In addition, Lexaria was awarded a patent in Japan in is antiviral agent patent family. The new patents bring the total of…

TuesdayApr 02, 2024 3:14 pm

TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Enters Acquisition Agreement to Acquire Biodefense Vaccine Developer

Aditxt (NASDAQ: ADTX), a company dedicated to discovering, developing and deploying promising health innovations, has signed a definitive arrangement agreement to acquire Appili Therapeutics Inc. (TSX: APLI) (OTCQX: APLIF). Appili is a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures. According to the agreement, Adivir Inc., a wholly owned subsidiary of Aditxt, will acquire all issued and outstanding Class A common shares of Appili. Assets acquired by Aditxt will include FDA-approved LIKMEZ(TM), which is the ATI-1701 tularemia vaccine defense program, and the ATI-1801 topical formulation. “The acquisition of Appili would represent another step in Aditxt’s journey towards…

MondayApr 01, 2024 3:57 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces FTZ Filing as ‘Strategic Initiative’

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has filed for Foreign Trade Zone (“FTZ”) status with the U.S. Department of Commerce; the company is filing for the status at its commercial vehicle manufacturing and assembly center in Tunica, Mississippi. According to the announcement, the company anticipates that FTZ status would provide key benefits, including the opportunity for improving company cash flow through reduction of taxes, fees and deferment of import duties. Specifically, Mullen projects that deferred working capital on domestic sales could result in deferred capital outlays of $10 million for the remainder of fiscal year 2024.…

MondayApr 01, 2024 3:44 pm

TinyGemsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q4, FY 2023 Financial Report, Operational Update

Vivos Therapeutics (NASDAQ: VVOS), a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, is reporting financial results and operating highlights for Q4 and full year 2023, for the period ended Dec. 31, 2023. The report noted that revenue came in at $3.2 million for Q4 2023 and $13.8 million for the full year; gross profit was $2.1 million for the Q4 2023 and $8.3 million for the full year; and gross margin totaled 64% for Q4 2023 and 60% for the full year. In addition, the company reported…

MondayApr 01, 2024 3:26 pm

TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Releases Year-End 2023 Financial Report, Business Update

Predictive Oncology (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial-intelligence (“AI”) and machine-learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility to accelerate oncologic drug discovery and enable drug development, is reporting on its financial and operating results for the year ended Dec. 31, 2023; the company also released a corporate update. The report noted POAI experienced a net loss of some $14 million on total revenue of approximately $1.8 million for the year; the company also reported a 50% reduction in basic and diluted net loss per common share for the full year 2023. In…

MondayApr 01, 2024 12:35 pm

TinyGemsBreaks — Cepton Inc. (NASDAQ: CPTN) Releases Q4, FY 2023 Financial Report, Business Update

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is reporting on its financial and business results for the fourth quarter and full year ending Dec. 31, 2023. The financial report included full-year 2023 revenue of $13.1 million, a 76% increase over the prior year and an increase over the full-year 2023 revenue guidance as well as Q4 2023 product revenue of $2.5 million, an increase of 152% compared to the same period in 2022; the company’s full-year gross margin was 27% with a Q4 2023 gross margin of 54%. Business highlight for the company included its…

TuesdayMar 26, 2024 3:59 pm

TinyGemsBreaks – NextPlat Corp. (NASDAQ: NXPL) Expands Technology E-Commerce Portfolio Through Strategic Acquisition

NextPlat (NASDAQ:NXPL, NXPLW), a global e-commerce provider, today announced the significant expansion of its North American e-commerce business with the acquisition of Outfitter Satellite Inc. through an all-cash transaction. According to the announcement, the transaction is expected to close on April 1, 2024. “Outfitter is an ideal addition to our technology e-commerce portfolio, delivering immediate synergies and value, quickly and profitably adding scale to our North American operations,” said Charles M. Fernandez, executive chairman and CEO of NextPlat. “Through acquisitions such as Outfitter and the introduction of new technology and healthcare e-commerce offerings expected later this year, we are executing…

ThursdayMar 21, 2024 2:45 pm

TinyGemsBreaks – Diamond Lake Minerals Inc. (DLMI) CEO Discusses Potential of Tokenization of Assets in Proactive Interview

Diamond Lake Minerals (OTC: DLMI), a leading multi-strategy operating company specializing in developing and supporting digital assets and SEC-registered security tokens, has been featured in an interview with Proactive Investors. DLMI CEO Brian J. Esposito joined Proactive’s Stephen Gunnion to discuss the company’s pioneering role in the development of digital assets and SEC-registered security tokens. Esposito talked about the potential of tokenization of financial assets in redefining investing, the challenges of traditional investment mechanisms in real estate and other sectors, importance of operating within regulatory frameworks, and the role of blockchain in tokenization. Esposito also explained DLMI’s strategic partnership with…

ThursdayMar 21, 2024 1:57 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO to Present at the Upcoming 14th Annual LD Micro Invitational

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced that it will be participating at the 14th Annual LD Micro Invitational at the Sofitel New York on Apr. 8-9, 2024. Lexaria CEO Chris Bunka will be presenting at the event, with his presentation scheduled to begin at 10:30 a.m. ET on Tuesday, Apr. 9. Bunka will discuss the company’s recent discovery of enhanced performance of glucagon-like-peptide-1 (“GLP-1”) drugs utilizing DehydraTECH. The presentation will also cover the highly anticipated upcoming animal and clinical studies in humans to more thoroughly evaluate the impact of DehydraTECH processing on…

ThursdayMar 21, 2024 1:34 pm

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Receives Notification from NASDAQ of 180-Day Extension

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, has been granted an additional 180 days to comply with NASDAQ’s minimum bid price requirement for the continued listing on the NASDAQ Capital Market. InMed received a letter from the exchange notifying it of the extended deadline, which will now be Sept. 16, 2024. According to the announcement, the compliance issues have no immediate effect on the listing or trading of the InMed Pharmaceuticals’ ordinary shares, which will continue to trade on the NASDAQ Capital Market. “NASDAQ's determination is based on…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (310) 299-1717

Breaks Categories: News